Meeting of the Healthcare Infection Control Practices Advisory Committee, 63432-63433 [2024-17220]

Download as PDF lotter on DSK11XQN23PROD with NOTICES1 63432 Federal Register / Vol. 89, No. 150 / Monday, August 5, 2024 / Notices whether the proposed collection of information is necessary for the proper performance of the functions of the Commission, including whether the information shall have practical utility; the accuracy of the Commission’s burden estimate; ways to enhance the quality, utility, and clarity of the information collected; ways to minimize the burden of the collection of information on the respondents, including the use of automated collection techniques or other forms of information technology; and ways to further reduce the information collection burden on small business concerns with fewer than 25 employees. DATES: Written PRA comments should be submitted on or before October 4, 2024. If you anticipate that you will be submitting comments, but find it difficult to do so within the period of time allowed by this notice, you should advise the contact listed below as soon as possible. ADDRESSES: Direct all PRA comments to Nicole Ongele, FCC, via email PRA@ fcc.gov and to nicole.ongele@fcc.gov. FOR FURTHER INFORMATION CONTACT: For additional information about the information collection, contact Nicole Ongele, (202) 418–2991. SUPPLEMENTARY INFORMATION: The FCC may not conduct or sponsor a collection of information unless it displays a currently valid control number. No person shall be subject to any penalty for failing to comply with a collection of information subject to the PRA that does not display a valid Office of Management and Budget (OMB) control number. OMB Control Number: 3060–0719. Title: Quarterly Report of Local Exchange Carriers Listing Payphone Automatic Number Identifications (ANIs). Form Number: N/A. Type of Review: Extension of a currently approved collection. Respondents: Business or other forprofit entities. Number of Respondents and Responses: 400 respondents; 1,600 responses. Estimated Time per Response: 3.5 hours (8 hours for the initial submission; 2 hours per subsequent submission, for an average of 3.5 hours per response). Frequency of Response: Quarterly reporting requirement, recordkeeping requirement, and third party disclosure requirement. Obligation to Respond: Required to obtain or retain benefits. Statutory authority for this information collection is contained in 47 U.S.C. 151, 154, 201– VerDate Sep<11>2014 18:38 Aug 02, 2024 Jkt 262001 205, 215, 218, 219, 220, 226 and 276 of the Communications Act of 1934, as amended. Total Annual Burden: 5,600 hours. Total Annual Cost: No cost. Needs and Uses: The Commission adopted rules and policies governing the payphone industry under section 276(b)(1)(A) of the Telecommunications Act of 1996 (the Act) and established ‘‘a per call compensation plan to ensure that all payphone service providers are fairly compensated for each and every completed intrastate and interstate call.’’ Pursuant to this mandate, and as required by section 64.1310(d) of the Commission’s rules, Local Exchange Carriers (LECs) must provide to carriers required to pay compensation pursuant to section 64.1300(a), a quarterly report listing payphone ANIs. Without provision of this report, resolution of disputed ANIs would be rendered very difficult. Carriers would not be able to discern which ANIs pertain to payphones and therefore would not be able to ascertain which dial-around calls were originated by payphones for compensation purposes. There would be no way to guard against possible fraud. Without this collection, lengthy investigations would be necessary to verify claims. The report allows carriers to determine which dial-around calls are made from payphones. The information must be provided to third parties. The requirement would be used to ensure that LECs and the carriers required to pay compensation pursuant to 47 CFR 64.1300(a) of the Commission’s rules comply with their obligations under the Telecommunications Act of 1996. Federal Communications Commission. Katura Jackson, Federal Register Liaison Officer. [FR Doc. 2024–17203 Filed 8–2–24; 8:45 am] BILLING CODE 6712–01–P FEDERAL ELECTION COMMISSION Sunshine Act Meetings Tuesday, August 13, 2024 at 10:00 a.m. and its continuation at the conclusion of the open meeting on August 15, 2024. PLACE: 1050 First Street NE, Washington, DC and virtual. (This meeting will be a hybrid meeting.) STATUS: This meeting will be closed to the public. MATTERS TO BE CONSIDERED: Compliance matters pursuant to 52 U.S.C. 30109. Matters relating to internal personnel decisions, or internal rules and practices. TIME AND DATE: PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 Information the premature disclosure of which would be likely to have a considerable adverse effect on the implementation of a proposed Commission action. Matters concerning participation in civil actions or proceedings or arbitration. * * * * * CONTACT PERSON FOR MORE INFORMATION: Judith Ingram, Press Officer, Telephone: (202) 694–1220. (Authority: Government in the Sunshine Act, 5 U.S.C. 552b) Vicktoria J. Allen, Deputy Secretary of the Commission. [FR Doc. 2024–17299 Filed 8–1–24; 11:15 am] BILLING CODE 6715–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Meeting of the Healthcare Infection Control Practices Advisory Committee Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention announces the following meeting for the Healthcare Infection Control Practices Advisory Committee (HICPAC). This virtual meeting is open to the public, limited only by the number of audio and web conference lines (500 audio and web conference lines are available). Time will be available for public comment. DATES: The meeting will be held on August 22, 2024, from 9 a.m. to 5 p.m., EDT. ADDRESSES: The meeting will be webcast live via the World Wide Web. The webcast link can be found on the HICPAC website: https://www.cdc.gov/ hicpac/meeting.html. FOR FURTHER INFORMATION CONTACT: Sydnee Byrd, M.P.A., Committee Management Specialist, Healthcare Infection Control Practices Advisory Committee, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H16–3, Atlanta, Georgia 30329–4027. Telephone: (404) 718– 8039; Email: hicpac@cdc.gov. SUPPLEMENTARY INFORMATION: SUMMARY: E:\FR\FM\05AUN1.SGM 05AUN1 Federal Register / Vol. 89, No. 150 / Monday, August 5, 2024 / Notices Purpose: The Committee is charged with providing advice and guidance to the Director, Division of Healthcare Quality Promotion (DHQP), the Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), the Director, CDC, and the Secretary, Department of Health and Human Services, regarding (1) the practice of healthcare infection prevention and control; (2) strategies for surveillance, prevention, and control of infections, antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of CDC guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. Matters to be Considered: The agenda will include the following updates: The Healthcare Personnel Guideline Workgroup; Isolation Precautions Guideline Workgroup; Dental Unit Waterlines Guideline Update; Division of Health Quality Promotion Updates; Review of Viral Hemorrhagic Fever Update; Pathogen Reduction Guidance Introduction; NHSN Update; Recommendation Categorization Framework Update. Agenda items are subject to change. lotter on DSK11XQN23PROD with NOTICES1 Public Participation Oral Public Comment: This meeting will include time for members of the public to make an oral comment. Priority will be given to individuals who submit a request to make an oral public comment before the meeting according to the procedures below. All persons interested in making an oral public comment at the August 22, 2024 HICPAC meeting must submit a request between July 26, 2024, and August 12, 2024, at https://www.cdc.gov/hicpac/ meeting.html no later than 11:59 p.m., EDT, August 12, 2024, according to the instructions provided on the HICPAC website. If the number of persons requesting to speak is greater than can be reasonably accommodated during the scheduled time, CDC will conduct a lottery to determine the speakers for the scheduled public comment session. CDC staff will notify individuals regarding their request to speak by email by August 17, 2024. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and VerDate Sep<11>2014 18:38 Aug 02, 2024 Jkt 262001 Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2024–17220 Filed 8–2–24; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Meeting of the Advisory Committee on Breast Cancer in Young Women Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces the following meeting of the Advisory Committee on Breast Cancer in Young Women (ACBCYW). This meeting is open to the public, limited only by conference room space and web Conference lines (40 conference room and 60 web conference participant spaces available). Online registration is required. DATES: The meeting will be held on September 13, 2024, from 8:30 a.m. to 4 p.m., EDT. ADDRESSES: 4770 Buford Highway, Atlanta, Georgia 30341, Building 106, Room 1B. All ACBCYW Meeting participants must register for the meeting online at least 5 business days in advance at https://www.cdc.gov/ breast-cancer/php/advisory-committee/ index.html. Please complete all the required fields and submit your registration no later than September 6, 2024. Registered participants will receive access instructions before the meeting. All visitors are required to present a valid form of picture identification issued by a state, federal or international government. As required by the Federal Property Management Regulations, all persons entering in or on Federal controlled property and their packages, briefcases, and other containers in their immediate possession are subject to being x-rayed and inspected. Federal law prohibits the knowing possession or the causing to be present of firearms, explosives and other dangerous weapons and illegal substances. Time will be available for public comment. The public is welcome SUMMARY: PO 00000 Frm 00036 Fmt 4703 Sfmt 9990 63433 to submit written comments in advance of the meeting. Comments should be submitted in writing by email to acbcyw@cdc.gov. The deadline for receipt is September 10, 2024. FOR FURTHER INFORMATION CONTACT: Kimberly E. Smith, M.B.A., M.H.A., Designated Federal Officer, Advisory Committee on Breast Cancer in Young Women, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway NE, Mailstop S107–4, Atlanta, Georgia 30341. Telephone: (404) 498–0073; Fax: (770) 488–4760; Email: acbcyw@ cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The Advisory Committee provides advice and guidance to the Secretary, HHS; the Assistant Secretary for Health; and the Director, CDC, regarding the formative research, development, implementation, and evaluation of evidence-based activities designed to prevent breast cancer (particularly among those at heightened risk) and promote the early detection and support of young women who develop the disease. The advice provided by the Advisory Committee will assist in ensuring scientific quality, timeliness, utility, and dissemination of credible appropriate messages and resource materials. Matters to be Considered: The agenda will include discussions on current topics related to breast cancer in young women. These will include Mental/ Behavioral Health, Sexual Health, Genetics and Genomics, and Provider Engagement. Agenda items are subject to change as priorities dictate. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2024–17219 Filed 8–2–24; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\05AUN1.SGM 05AUN1

Agencies

[Federal Register Volume 89, Number 150 (Monday, August 5, 2024)]
[Notices]
[Pages 63432-63433]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-17220]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Meeting of the Healthcare Infection Control Practices Advisory 
Committee

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention announces the following 
meeting for the Healthcare Infection Control Practices Advisory 
Committee (HICPAC). This virtual meeting is open to the public, limited 
only by the number of audio and web conference lines (500 audio and web 
conference lines are available). Time will be available for public 
comment.

DATES: The meeting will be held on August 22, 2024, from 9 a.m. to 5 
p.m., EDT.

ADDRESSES: The meeting will be webcast live via the World Wide Web. The 
webcast link can be found on the HICPAC website: https://www.cdc.gov/hicpac/meeting.html.

FOR FURTHER INFORMATION CONTACT: Sydnee Byrd, M.P.A., Committee 
Management Specialist, Healthcare Infection Control Practices Advisory 
Committee, Division of Healthcare Quality Promotion, National Center 
for Emerging and Zoonotic Infectious Diseases, Centers for Disease 
Control and Prevention, 1600 Clifton Road NE, Mailstop H16-3, Atlanta, 
Georgia 30329-4027. Telephone: (404) 718-8039; Email: [email protected].

SUPPLEMENTARY INFORMATION: 

[[Page 63433]]

    Purpose: The Committee is charged with providing advice and 
guidance to the Director, Division of Healthcare Quality Promotion 
(DHQP), the Director, National Center for Emerging and Zoonotic 
Infectious Diseases (NCEZID), the Director, CDC, and the Secretary, 
Department of Health and Human Services, regarding (1) the practice of 
healthcare infection prevention and control; (2) strategies for 
surveillance, prevention, and control of infections, antimicrobial 
resistance, and related events in settings where healthcare is 
provided; and (3) periodic updating of CDC guidelines and other policy 
statements regarding prevention of healthcare-associated infections and 
healthcare-related conditions.
    Matters to be Considered: The agenda will include the following 
updates: The Healthcare Personnel Guideline Workgroup; Isolation 
Precautions Guideline Workgroup; Dental Unit Waterlines Guideline 
Update; Division of Health Quality Promotion Updates; Review of Viral 
Hemorrhagic Fever Update; Pathogen Reduction Guidance Introduction; 
NHSN Update; Recommendation Categorization Framework Update. Agenda 
items are subject to change.

Public Participation

    Oral Public Comment: This meeting will include time for members of 
the public to make an oral comment. Priority will be given to 
individuals who submit a request to make an oral public comment before 
the meeting according to the procedures below. All persons interested 
in making an oral public comment at the August 22, 2024 HICPAC meeting 
must submit a request between July 26, 2024, and August 12, 2024, at 
https://www.cdc.gov/hicpac/meeting.html no later than 11:59 p.m., EDT, 
August 12, 2024, according to the instructions provided on the HICPAC 
website. If the number of persons requesting to speak is greater than 
can be reasonably accommodated during the scheduled time, CDC will 
conduct a lottery to determine the speakers for the scheduled public 
comment session. CDC staff will notify individuals regarding their 
request to speak by email by August 17, 2024.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-17220 Filed 8-2-24; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.